121 related articles for article (PubMed ID: 37268521)
21. Mitoxantrone: a review of its use in multiple sclerosis.
Scott LJ; Figgitt DP
CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
[TBL] [Abstract][Full Text] [Related]
22. Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study.
Long GV; Atkinson V; Lo S; Sandhu S; Guminski AD; Brown MP; Wilmott JS; Edwards J; Gonzalez M; Scolyer RA; Menzies AM; McArthur GA
Lancet Oncol; 2018 May; 19(5):672-681. PubMed ID: 29602646
[TBL] [Abstract][Full Text] [Related]
23. Electrochemotherapy with intravenous bleomycin for patients with cutaneous malignancies, across tumour histology: a systematic review.
Bastrup FA; Vissing M; Gehl J
Acta Oncol; 2022 Sep; 61(9):1093-1104. PubMed ID: 36036195
[TBL] [Abstract][Full Text] [Related]
24. Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion study.
Lakhani NJ; Chow LQM; Gainor JF; LoRusso P; Lee KW; Chung HC; Lee J; Bang YJ; Hodi FS; Kim WS; Santana-Davila R; Fanning P; Squifflet P; Jin F; Kuo TC; Wan HI; Pons J; Randolph SS; Messersmith WA
Lancet Oncol; 2021 Dec; 22(12):1740-1751. PubMed ID: 34793719
[TBL] [Abstract][Full Text] [Related]
25. Phase 1/2 study of topical submicron particle paclitaxel for cutaneous metastases of breast cancer.
Lacouture ME; Goldfarb SB; Markova A; Chawla SP; Dewnani K; Iacobucci M; Lang JE
Breast Cancer Res Treat; 2022 Jul; 194(1):57-64. PubMed ID: 35471470
[TBL] [Abstract][Full Text] [Related]
26. Endoscopic calcium electroporation for colorectal cancer: a phase I study.
Broholm M; Vogelsang R; Bulut M; Stigaard T; Falk H; Frandsen S; Pedersen DL; Perner T; Fiehn AK; Mølholm I; Bzorek M; Rosen AW; Andersen CSA; Pallisgaard N; Gögenur I; Gehl J
Endosc Int Open; 2023 May; 11(5):E451-E459. PubMed ID: 37180313
[No Abstract] [Full Text] [Related]
27. Ablation of colorectal liver metastases by irreversible electroporation: results of the COLDFIRE-I ablate-and-resect study.
Scheffer HJ; Nielsen K; van Tilborg AA; Vieveen JM; Bouwman RA; Kazemier G; Niessen HW; Meijer S; van Kuijk C; van den Tol MP; Meijerink MR
Eur Radiol; 2014 Oct; 24(10):2467-75. PubMed ID: 24939670
[TBL] [Abstract][Full Text] [Related]
28. Percutaneous ethanol injection for liver metastases.
Swierz MJ; Storman D; Riemsma RP; Wolff R; Mitus JW; Pedziwiatr M; Kleijnen J; Bala MM
Cochrane Database Syst Rev; 2020 Feb; 2(2):CD008717. PubMed ID: 32017845
[TBL] [Abstract][Full Text] [Related]
29. Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial.
Planchard D; Besse B; Groen HJM; Souquet PJ; Quoix E; Baik CS; Barlesi F; Kim TM; Mazieres J; Novello S; Rigas JR; Upalawanna A; D'Amelio AM; Zhang P; Mookerjee B; Johnson BE
Lancet Oncol; 2016 Jul; 17(7):984-993. PubMed ID: 27283860
[TBL] [Abstract][Full Text] [Related]
30. A Review on Differences in Effects on Normal and Malignant Cells and Tissues to Electroporation-Based Therapies: A Focus on Calcium Electroporation.
Frandsen SK; Gehl J
Technol Cancer Res Treat; 2018 Jan; 17():1533033818788077. PubMed ID: 30012047
[TBL] [Abstract][Full Text] [Related]
31. Dose-dependent ATP depletion and cancer cell death following calcium electroporation, relative effect of calcium concentration and electric field strength.
Hansen EL; Sozer EB; Romeo S; Frandsen SK; Vernier PT; Gehl J
PLoS One; 2015; 10(4):e0122973. PubMed ID: 25853661
[TBL] [Abstract][Full Text] [Related]
32. Folliculotropic Cutaneous Metastases and Lymphangitis Carcinomatosa: When Cutaneous Metastases of Breast Carcinoma Are Mistaken for Cutaneous Infections.
Paolino G; Panetta C; Didona D; Donati M; Donati P
Acta Dermatovenerol Croat; 2016 Jun; 24(2):154-7. PubMed ID: 27477179
[TBL] [Abstract][Full Text] [Related]
33. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study.
Gomez DR; Blumenschein GR; Lee JJ; Hernandez M; Ye R; Camidge DR; Doebele RC; Skoulidis F; Gaspar LE; Gibbons DL; Karam JA; Kavanagh BD; Tang C; Komaki R; Louie AV; Palma DA; Tsao AS; Sepesi B; William WN; Zhang J; Shi Q; Wang XS; Swisher SG; Heymach JV
Lancet Oncol; 2016 Dec; 17(12):1672-1682. PubMed ID: 27789196
[TBL] [Abstract][Full Text] [Related]
34. Electrochemotherapy in the treatment of cutaneous malignancy: Outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008-2019).
Clover AJP; de Terlizzi F; Bertino G; Curatolo P; Odili J; Campana LG; Kunte C; Muir T; Brizio M; Sersa G; Pritchard Jones R; Moir G; Orlando A; Banerjee SM; Kis E; McCaul JA; Grischke EM; Matteucci P; Mowatt D; Bechara FG; Mascherini M; Lico V; Giorgione R; Seccia V; Schepler H; Pecorari G; MacKenzie Ross AD; Bisase B; Gehl J
Eur J Cancer; 2020 Oct; 138():30-40. PubMed ID: 32836172
[TBL] [Abstract][Full Text] [Related]
35. Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial.
Herbst RS; Arkenau HT; Santana-Davila R; Calvo E; Paz-Ares L; Cassier PA; Bendell J; Penel N; Krebs MG; Martin-Liberal J; Isambert N; Soriano A; Wermke M; Cultrera J; Gao L; Widau RC; Mi G; Jin J; Ferry D; Fuchs CS; Petrylak DP; Chau I
Lancet Oncol; 2019 Aug; 20(8):1109-1123. PubMed ID: 31301962
[TBL] [Abstract][Full Text] [Related]
36. Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.
Daud AI; DeConti RC; Andrews S; Urbas P; Riker AI; Sondak VK; Munster PN; Sullivan DM; Ugen KE; Messina JL; Heller R
J Clin Oncol; 2008 Dec; 26(36):5896-903. PubMed ID: 19029422
[TBL] [Abstract][Full Text] [Related]
37. Electrochemotherapy as a New Modality in Interventional Oncology: A Review.
Probst U; Fuhrmann I; Beyer L; Wiggermann P
Technol Cancer Res Treat; 2018 Jan; 17():1533033818785329. PubMed ID: 29986632
[TBL] [Abstract][Full Text] [Related]
38. Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation.
Gothelf A; Mir LM; Gehl J
Cancer Treat Rev; 2003 Oct; 29(5):371-87. PubMed ID: 12972356
[TBL] [Abstract][Full Text] [Related]
39. ESOPE-Equivalent Pulsing Protocols for Calcium Electroporation: An In Vitro Optimization Study on 2 Cancer Cell Models.
Romeo S; Sannino A; Scarfì MR; Vernier PT; Cadossi R; Gehl J; Zeni O
Technol Cancer Res Treat; 2018 Jan; 17():1533033818788072. PubMed ID: 30021498
[TBL] [Abstract][Full Text] [Related]
40. Electrochemotherapy for colorectal cancer using endoscopic electroporation: a phase 1 clinical study.
Falk Hansen H; Bourke M; Stigaard T; Clover J; Buckley M; O'Riordain M; Winter DC; Hjorth Johannesen H; Hansen RH; Heebøll H; Forde P; Jakobsen HL; Larsen O; Rosenberg J; Soden D; Gehl J
Endosc Int Open; 2020 Feb; 8(2):E124-E132. PubMed ID: 32010744
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
